Steve Dobbs, the CEO of Urologic Specialists of Oklahoma, Inc, discusses the viability, legality, and successful implementation of an office-based medication-dispensing solution.
By Steve Dobbs
Advertisement
Articles by By Steve Dobbs
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
PAPILLON: Frontline Amivantamab Plus Chemotherapy Yields 34.3-Month Median OS in EGFR Exon 20 Insertion–Positive NSCLC
2
Adjuvant Osimertinib Keeps OS Benefit at 8 Years in Resected EGFR-Mutated Stage IB to IIIA NSCLC
3
FDA Approves Aminolevulinic Acid Hydrochloride Plus PDT for Basal Cell Carcinoma
4
FDA Approves Reduced Monitoring Time for First 2 Doses of Tarlatamab in ES-SCLC
5